Callio Therapeutics
Series A in 2025
Callio Therapeutics specializes in the development of advanced antibody-drug conjugates (ADCs) for cancer treatment. Their focus is on creating multi-payload ADCs, which allow for the targeted delivery of drug combinations to tumor cells, potentially maximizing therapeutic benefits and improving patient outcomes.
Island is a cybersecurity company that specializes in enterprise browser solutions. It offers a web browser tailored for businesses, enabling secure and efficient work environments. Island's platform provides organizations with comprehensive control, visibility, and governance over their online activities, enhancing performance and minimizing cybersecurity risks. The company fosters a collaborative work culture, valuing integrity, quality, and honesty in its interactions with clients.
Zinc Money
Seed Round in 2024
Zinc Money provides fast and secure international money transfers, specializing in helping students and individuals send money from India. With the convenience of UPI integration, users can now transfer funds abroad effortlessly. Zinc Money offers quick and affordable money transfer solutions for education, travel, and everyday expenses with transparent fees and strong security. Whether you need to send money internationally or manage global transactions, Zinc simplifies the process, making it an ideal choice for users transferring money from India.
Sunbird Bio
Venture Round in 2024
Sunbird Bio is a diagnostics platform developer focused on advancing molecular diagnostics to deliver faster and more accurate results. Founded by Huilin Shao, the company specializes in detecting a wide array of diseases, including infectious diseases, neurodegenerative disorders, and cancer. By enabling early diagnosis, Sunbird Bio aims to enhance healthcare outcomes and support physicians in making informed decisions. The platform is designed to improve clarity and accessibility in diagnostic testing, thereby contributing to better patient care.
Arta Finance
Venture Round in 2024
Arta Finance is a fintech company established in 2021 by a team of former Google executives, focused on creating a digital family office that democratizes wealth management. The company aims to provide the benefits of traditional family offices—such as personalized financial strategies and comprehensive wealth management—at a lower cost and with fewer barriers to entry. By leveraging artificial intelligence and machine learning, Arta Finance offers innovative consumer financing solutions that simplify access to financial markets for a broader audience. The company seeks to empower its members to grow, protect, and enjoy their wealth in a more accessible and efficient manner.
Riverlane
Series C in 2024
Riverlane is a developer of quantum computing software focused on transforming experimental technology into commercial products. The company engineers innovative instruments in collaboration with quantum computer manufacturers, addressing the need for new hardware and software tools to manage the instability of qubits and rectify system defects at unprecedented speeds. Riverlane's software includes an ultra-low latency quantum operating system that accelerates quantum-classical hybrid algorithms, supporting hardware research and development. Additionally, the company creates algorithms designed to optimize the use of the entire quantum computing stack, assisting hardware partners in minimizing the system errors that currently challenge quantum computing capabilities.
ShareChat
Debt Financing in 2024
ShareChat is an Indian social media startup founded in 2015 and headquartered in Bangalore, Karnataka. It provides a content consumption and sharing platform specifically designed for the diverse vernacular audience in India, supporting 15 Indian languages. The platform caters to over 1.17 billion wireless network users in the country, allowing them to share videos, jokes, songs, and other social content. ShareChat includes features for private messaging and tagging, making it easy for users to connect and communicate in their preferred language.
Leo Cancer Care
Series C in 2024
Leo Cancer Care is an innovative company based in Australia that focuses on enhancing the patient experience in cancer radiation therapy. The company has developed a specialized treatment system that emphasizes the clinical benefits of upright patient positioning, which aims to improve patient comfort and control during treatment. By integrating advanced technology with a radiotherapy machine, Leo Cancer Care's system facilitates 3D image capturing and precise control of radiation beams, ensuring that the appropriate amount of energy is delivered to targeted tissues. This approach not only simplifies the radiation therapy process but also aims to reduce the pain and costs associated with traditional chemotherapy and radiation treatments, ultimately connecting patients to centralized cancer care centers for more effective treatment options.
Artera
Venture Round in 2024
Artera develops medical artificial intelligence tests that personalize therapy for cancer patients. Its tests predict therapeutic benefits and prognosticate patient outcomes. The Artera platform is purely software, and runs on digital images of H&E histopathology images as part of routine clinical care.
LXA is a fintech venture focused on reimagining Asia's mortgage ecosystem. Geared towards matching institutional capital pools and residential mortgage borrowers, this platform aims to utilize end-to-end technology to streamline the entire mortgage lifecycle, from loan origination and borrower processing to loan servicing. LXA was founded in early 2023 by seasoned executives across the asset management, insurance, mortgage, and technology industries to bridge the gap between mortgage assets and institutional capital in Asia, beginning with Singapore. Combining best practices from North American and European markets with a proprietary technology platform focused on digital credit decisioning and intelligent workflow orchestration, LXA provides the first of its kind solution to address strong demand from Asian insurers and borrowers for differentiated mortgage products.
Engine Biosciences
Series A in 2023
Engine Biosciences, established in 2014 and headquartered in Singapore, specializes in drug discovery and cellular reprogramming. The company's core offering is a validated platform that combines artificial intelligence and genetic perturbation to uncover gene interactions and biological networks. This platform enables researchers and drug developers to create targeted therapies and apply precision medicine. Engine Biosciences caters to prominent American corporations and research institutions, accelerating and reducing the costs of R&D for new medical therapies.
Automera is a biotechnology company specializing in the development of innovative therapeutic methods for drug discovery. The firm focuses on creating autophagy-targeting drugs designed to address specific diseases. Utilizing advanced computational chemistry, artificial intelligence, and quantum molecular dynamics, Automera's technology enables the design of chimeric small molecules that can simultaneously bind to autophagy pathways and selected disease targets. This approach acts as a natural defense mechanism against viruses and bacteria, allowing for the identification and development of effective drugs that harness the body's own systems to combat diseases.
Endowus is a financial advisory and personalized investment company focused on helping clients grow their wealth. It offers access to institutional share-class funds typically reserved for large investors, allowing retail investors to benefit from lower fees associated with institutional-level investments. The company provides a comprehensive service that includes financial advice, investment management, portfolio rebalancing, and brokerage services, all under a single access fee. By connecting clients with funds managed by reputable global investment management firms, Endowus aims to deliver attractive returns and financial growth opportunities that are usually unavailable to individual investors.
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.
Engine Biosciences
Series A in 2023
Engine Biosciences, established in 2014 and headquartered in Singapore, specializes in drug discovery and cellular reprogramming. The company's core offering is a validated platform that combines artificial intelligence and genetic perturbation to uncover gene interactions and biological networks. This platform enables researchers and drug developers to create targeted therapies and apply precision medicine. Engine Biosciences caters to prominent American corporations and research institutions, accelerating and reducing the costs of R&D for new medical therapies.
Moloco
Secondary Market in 2023
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.
EdgeQ Inc., established in 2018 with headquarters in Santa Clara, California, develops and manufactures open and programmable 5G system-on-a-chip (SoC). The company specializes in converged connectivity and AI, offering fully software-customizable solutions. EdgeQ serves a diverse range of industries including manufacturing, construction, energy, automotive, warehousing, surveillance, and telecommunications. Its products enable collaborative robotics, automated guided vehicles, autonomous driving, traffic management, digital twins, and private networking for innovative applications across various sectors.
Thunes is a global B2B payment infrastructure platform established in 2016, specializing in cross-border payment solutions. It facilitates seamless fund transfers between various payment systems, catering to a diverse range of clients, including major players in the gig economy and fintech sectors. The platform enables businesses and consumers to send and receive payments in 80 currencies across 132 countries, supporting 300 payment methods. Thunes offers a suite of services including remittance processing, mass payouts, virtual accounts, and payment collection, utilizing application programming interfaces (APIs) to enhance accessibility and reduce transaction costs. In April 2022, the company expanded its capabilities by acquiring a controlling stake in Tookitaki, a compliance platform that strengthens its anti-money laundering and fraud prevention measures. Headquartered in Singapore, Thunes operates regional offices in key global cities such as London, Paris, and Dubai, positioning itself as a vital player in the international payment landscape.
Proxtera
Seed Round in 2023
Proxtera is a global trading network platform focused on simplifying cross-border trade and empowering micro, small, and medium enterprises (MSMEs). By leveraging artificial intelligence, Proxtera helps users discover pricing and sales opportunities in the broader global marketplace. The platform enables access to diverse supply chains and facilitates the creation of an open market infrastructure. Furthermore, Proxtera employs relevant digital and financial technologies to aid digital service providers and trade associations in the digitalization of small and medium enterprises. This approach enhances the accessibility, availability, and affordability of innovative digital solutions for businesses seeking to expand their reach and capabilities in international trade.
LionsBot International is a Singapore-based robotics company specializing in the development of cleaning robots designed for commercial, industrial, and public spaces. With a strong foundation in cleaning and robotics, the company creates versatile and efficient cleaning solutions that maximize speed and efficacy. Featuring advanced technologies such as human-centered AI, 3D LiDAR sensors, and auto docking mechanics, LionsBot's robots can vacuum and scrub large areas efficiently. The entire design and engineering process is handled in-house, ensuring a deep understanding of their product's capabilities and reliability. LionsBot aims to enhance everyday living for over 50 million people with innovative cleaning solutions that are both effective and user-friendly.
Doctor Anywhere
Series C in 2022
Doctor Anywhere is a Singapore-based telehealth company that offers a comprehensive digital platform for on-demand healthcare solutions. It provides quick access to a range of health and wellness services, allowing users to consult licensed medical professionals for diagnoses, medications, and e-prescriptions from anywhere and at any time. The platform is designed to be simple and convenient, catering to the evolving lifestyle preferences of modern users. By leveraging technology, Doctor Anywhere aims to enhance health outcomes and address contemporary healthcare challenges, making it easier for individuals to manage their health according to their specific needs.
Resolve BioSciences
Series B in 2022
Resolve BioSciences GmbH, founded in 2016 and based in Monheim am Rhein, Germany, specializes in spatial multiomics analysis platforms that enhance the understanding of single-cell spatial biology. The company's innovative technology enables researchers to obtain high-resolution spatial views of subcellular gene expression activities. Resolve BioSciences offers a range of services that encompass bioinformatics, imaging, genomics, transcriptomics, histology, and pathology, among others. Their expertise extends to various fields, including neuroscience, oncology, infectious diseases, and agrigenomics, facilitating advanced studies in cell atlasing and single-cell analysis.
Structo
Venture Round in 2022
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its proprietary hardware technology. By focusing on enhancing the speed and efficiency of 3D printing, Structo enables users to achieve higher throughput at lower costs compared to traditional stereolithography (SLA) printers. Their innovative approach allows dental professionals to revolutionize their business models while maintaining high print quality.
ImmunoScape
Venture Round in 2022
ImmunoScape is a biotechnology company specializing in immunomics, focused on advancing immune profiling and characterization of the human immune response with high precision. The company utilizes its Deep Immunomics platform, which integrates mass cytometry, single-cell sequencing, and proprietary computational bioinformatics tools to deliver detailed and reproducible immune profiling data. This innovative approach supports various therapeutic areas, particularly oncology and infectious diseases, by enhancing the understanding of immunotherapy safety and efficacy while aiding in the identification of drug targets. Additionally, ImmunoScape offers a suite of software tools for immune cell profiling and antigen-specific T-cell identification, providing valuable insights during the research and development phases of immunotherapy clinical trials.
Fazz is a financial technology company based in Singapore and Indonesia, founded in 2016. It focuses on providing digital financial services to enhance financial inclusion across Southeast Asia, particularly targeting underserved segments such as micro and small enterprises. Fazz offers a range of services including payment processing, banking, and investment solutions tailored for small businesses, startups, and large corporations. Its flagship offerings include Fazz Agen, an agent-based financial application designed for micro and small businesses, and Fazz Business, a comprehensive business account that facilitates payments, capital growth, and funding opportunities. The merger of PayFazz and Xfers has strengthened Fazz's position in the fintech landscape, enabling it to deliver diverse financial services to consumers and businesses alike.
Pico
Private Equity Round in 2022
Pico is a prominent provider of technology services tailored for the financial markets sector. The company offers a comprehensive network platform that enables clients to access financial markets instantly. This platform is enhanced with advanced analytics and telemetry capabilities, ensuring transparency and low-latency solutions. Pico's innovative approach allows clients to operate efficiently and gain a competitive advantage in the rapidly evolving financial landscape. Its agile service delivery model further supports the needs of clients seeking to navigate the complexities of financial trading effectively.
Wefox is a technology company specializing in the insurance sector. It operates a digital platform that connects insurance providers, brokers, businesses, and customers, facilitating access to various insurance solutions. The company focuses on indirect sales, partnering with intermediaries to expand its market reach. Wefox's platform offers services such as policy management, claims settlement, and quotation generation for a range of insurance types, including health, liability, and disability.
DataStax
Private Equity Round in 2022
DataStax, Inc. is a provider of database software specifically designed for cloud applications, catering to Fortune 100 companies both in the United States and internationally. The company offers a range of products including DataStax Enterprise, which is based on Apache Cassandra and supports online applications requiring high performance and reliability. Additionally, DataStax provides tools such as OpsCenter for database management and monitoring, K8ssandra for deploying Cassandra on Kubernetes, and Astra, a database-as-a-service that significantly reduces deployment time. With a focus on real-time processing, DataStax also enables the building of generative AI applications through its vector database, which supports developers with various integration capabilities. The company's services are complemented by training, certification, support, and consulting. Founded in 2010 and headquartered in Santa Clara, California, DataStax has expanded its presence with offices in multiple global locations including the United Kingdom, Japan, France, Germany, Australia, and Ireland.
Tessa Therapeutics
Series A in 2022
Tessa Therapeutics is a biotechnology company specializing in T cell therapy aimed at treating cancer, particularly solid tumors and lymphoma. The company focuses on developing both autologous and allogeneic cell therapies, including virus-specific T-cells and CAR T cells. Tessa Therapeutics aims to harness the body's anti-viral immune response to target and eliminate cancer cells, thereby transforming cancer treatment and enhancing the quality of life for patients. Through its innovative platform, Tessa Therapeutics is committed to advancing therapeutic options for healthcare providers and improving patient outcomes in the fight against cancer.
Neuron Mobility
Series B in 2022
Neuron Mobility is a rental e-scooter and e-bike company focused on providing safe and convenient transportation solutions for urban commuting. The company operates a fleet of distinctive orange e-scooters, which are designed and manufactured in-house to meet commercial standards, ensuring enhanced performance and durability compared to standard models. Utilizing high-accuracy location technology and rapid geofence detection, Neuron Mobility effectively monitors and corrects unsafe riding behavior, promoting a safer riding experience. The company's platform integrates real-time telematics to cater to various segments, including personal mobility, goods delivery, and tourism, thereby facilitating affordable and comfortable short-distance travel for city residents.
RVAC Medicines
Series B in 2022
RVAC Medicines is an innovative mRNA platform company founded in 2021 and based in Singapore. The company focuses on developing a diverse pipeline of novel mRNA vaccines and therapeutics to address unmet medical needs, particularly in emerging markets. RVAC Medicines offers end-to-end GMP manufacturing capabilities and maintains infrastructure for process scale-up and technology transfer. Its research and development efforts, combined with external partnerships, facilitate the creation of advanced mRNA and nucleic acid delivery technologies. The company's mission is to empower healthcare professionals in tackling infectious diseases through its cutting-edge solutions.
Biofourmis
Series D in 2022
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.
Us2.ai is a Singapore-based company that specializes in developing software and digital tools for echocardiography using artificial intelligence. The company's platform automates the manual process of measuring and interpreting echocardiograms, which are ultrasound images of the heart. This automation provides decision support tools designed to save doctors time, improve clinical trials for pharmaceutical companies, and enhance the detection of hard-to-diagnose cardiovascular conditions in hospitals. Us2.ai aims to simplify access to results of echo analysis and heart ultrasound through its online solutions.
Maya
Convertible Note in 2022
Maya is a Philippines-based technology company and a wholly-owned subsidiary of Smart Communications, Inc., operating under the umbrella of First Pacific. The company specializes in providing innovative digital solutions aimed at developing new business streams and adapting to evolving business models. Maya offers a comprehensive range of services, including merchant acquiring, domestic and international remittance, payment acceptance, mobile payments, card issuing, and digital financial services. Additionally, the company focuses on digital payments, e-wallets, digital lending, and digital banking, positioning itself as a key player in the financial technology sector and addressing the growing demand for modern, efficient financial solutions.
Beam Mobility Holdings Pte. Ltd. is a micro-mobility company that offers electric scooters for rent through a user-friendly mobile application. Established in 2018 and based in Singapore, Beam aims to enhance urban mobility by providing a network of shared e-scooters that can be easily accessed on a pay-per-use basis. The company promotes responsible parking by incentivizing users to return scooters to designated parking spots, thereby minimizing clutter on city streets. By leveraging Internet of Things technology, Beam contributes to improved last-mile connectivity, helps alleviate traffic congestion, and supports environmental sustainability efforts.
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.
Modalku is an online marketplace based in Jakarta, Indonesia, designed to connect small businesses seeking loans with lenders looking to fund these loans. By leveraging technology, Modalku offers borrowers access to financing options that may not be available through traditional channels, often at lower interest rates. Lenders participating in the platform can achieve returns that surpass those typically found in bank deposits and traditional investment products. This marketplace lending model has been successfully implemented in various countries, including the USA, UK, China, and Singapore, demonstrating its effectiveness in supporting small business growth.
Funding Societies
Series C in 2022
Funding Societies, established in 2015 and headquartered in Singapore, operates a digital financing platform that connects small and medium-sized enterprises (SMEs) with investors. The company facilitates business loans, focusing on quick and efficient financing solutions, often bypassing traditional banking methods. It offers a range of flexible financing options, including micro and term loans, and invoice financing, using advanced credit scoring and risk assessment models. With operations across Southeast Asia, including Singapore, Malaysia, Indonesia, and Thailand, Funding Societies caters to SMEs seeking accessible and timely financing.
Next Gen Foods
Series A in 2022
Next Gen Foods is a food-tech startup that offers plant-based meat products. Its plant-based products look and taste like meat and are developed using agricultural food ecosystems helping consumers to have foods that are rich in protein and nutrients. The company was founded in 2020 and is headquartered in Singapore.
Hazel Technologies
Venture Round in 2022
Hazel Technologies, Inc. is a biotechnology company focused on reducing waste in the agricultural supply chain through innovative packaging solutions. Founded in 2015 and headquartered in Chicago, Illinois, with an additional facility in Salinas, California, the company designs and manufactures packaging inserts, such as sachets, that are placed in produce boxes at the time of harvest. These inserts utilize ethylene inhibitors to slow the aging process of fruits and vegetables, thereby extending their shelf life and reducing spoilage. Hazel Technologies also offers agricultural and horticultural consulting services to growers and shippers, helping them improve the efficiency of their operations. The effectiveness of their products is supported by research from independent academic institutions, and the company has received funding from the United States Department of Agriculture to further its mission of combating food waste and enhancing profitability within the fresh produce sector.
Sleek is a digital platform that offers comprehensive corporate services aimed at facilitating company registration, compliance, and financial management for small and medium enterprises. The company simplifies business operations by providing a range of services, including company incorporation, accounting, tax management, payroll, and regulatory compliance. By automating administrative tasks that can often hinder entrepreneurs, Sleek enables clients to efficiently manage their business governance online. Its mission is to enhance the entrepreneurial experience by streamlining processes and reducing the complexity associated with starting and running a business.
Bolttech is an international InsurTech company specializing in AI-driven point-of-sale insurance solutions. Its platform offers a wide range of insurance products including device protection, travel, motor, property, life, and digital insurance to consumers worldwide, with a significant presence in Asia. Bolttech's technology enables seamless connections between insurers, distributors, and customers, facilitating efficient buying and selling of insurance products.
Ember is a design-led brand specializing in temperature control technology, founded by inventor Clay Alexander. The company aims to transform the way individuals consume food and beverages through its innovative products. Ember's flagship offerings include the Ember Travel Mug and Ember Mug, both recognized for their advanced temperature control capabilities, allowing users to set and maintain their preferred drinking temperatures for hot beverages. These products enhance the flavor experience of drinks like coffee and tea by enabling personalized temperature settings. Ember's smart mugs are sold in prominent retail outlets, including Best Buy, Apple, Williams Sonoma, Costco, and Target. In addition to its core drinkware line, Ember is expanding its temperature control technology into new sectors such as healthcare and infant feeding, demonstrating its commitment to innovation and customization in everyday living.
Endowus
Venture Round in 2021
Endowus is a financial advisory and personalized investment company focused on helping clients grow their wealth. It offers access to institutional share-class funds typically reserved for large investors, allowing retail investors to benefit from lower fees associated with institutional-level investments. The company provides a comprehensive service that includes financial advice, investment management, portfolio rebalancing, and brokerage services, all under a single access fee. By connecting clients with funds managed by reputable global investment management firms, Endowus aims to deliver attractive returns and financial growth opportunities that are usually unavailable to individual investors.
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.
Advance Intelligence Group
Series D in 2021
Advance Intelligence Group is a financial technology firm that builds an ecosystem of AI-powered, credit-enabled products, and services. Founded in 2016, it leverages innovative technology and partnerships to build an ecosystem of products and services serving consumers, enterprises, and merchants.
Neuroglee Health
Series A in 2021
Neuroglee Health is a digital therapeutic platform focused on addressing the needs of patients in the early stages of neurodegenerative diseases. The company develops innovative therapeutic devices that offer treatment and monitoring tools aimed at preserving cognitive function and promoting patient independence. By utilizing cognitive and neurobehavioral mechanisms, Neuroglee Health engages users on an individual basis, enabling them to take an active role in their treatment. The platform also provides consistent insights into the efficacy of therapies, which can facilitate accelerated drug development. Through its comprehensive approach, Neuroglee Health aims to empower patients and improve their quality of life while navigating the challenges posed by neurodegenerative conditions.
Nature's Fynd
Series C in 2021
Nature's Fynd is a food company that specializes in producing protein from extremophile organisms discovered in geothermal springs. Founded in 2012 and headquartered in Chicago, Illinois, with an additional office in Bozeman, Montana, the company employs innovative fermentation technology to cultivate its protein. This method significantly reduces the land and water resources typically required for traditional agriculture. Nature's Fynd aims to create foods that not only nourish people but also promote environmental sustainability.
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.
AvePoint, Inc. is a leading provider of software solutions and services designed for users of SharePoint and Office 365, focusing on data migration, management, and protection. Founded in 2001 and headquartered in Jersey City, New Jersey, the company serves over 21,000 customers globally, ensuring data security and compliance across various cloud environments, including Microsoft, Google, and Salesforce. AvePoint offers a range of products, including compliance solutions that address privacy and information security risks, as well as tools for data protection, operational governance, and records management. Its Confidence Platform provides cloud-based solutions for IT operations, development operations, and cybersecurity, facilitating secure collaboration and digital transformation. The company's extensive partner program includes over 3,500 managed service providers and systems integrators, making its solutions available in more than 100 cloud marketplaces.
SCI Ecommerce
Venture Round in 2021
SCI Ecommerce is a digital commerce software provider that specializes in marketing services designed to enhance brand awareness and conversion rates for its clients. The company focuses on creating data-driven, user-specific marketing campaigns that facilitate connections with target audiences and drive sales across various platforms. SCI Ecommerce supports businesses by offering comprehensive solutions, including the development of online storefronts and the production of high-quality content aligned with clients' objectives and brand image. Additionally, the company assists clients in navigating complex supply chains, ultimately enabling them to achieve robust growth and increased profitability.
Nuevocor is a preclinical-stage biopharmaceutical company dedicated to developing gene therapy-based treatments aimed at restoring cardiac function in hearts affected by disease. The company specializes in addressing genetic cardiomyopathies, which are characterized by abnormal mechanobiology. By focusing on modulating mechanical force transduction, Nuevocor seeks to provide innovative solutions that enable healthcare professionals to improve cardiac function in patients suffering from these conditions.
Engine Biosciences
Series A in 2021
Engine Biosciences, established in 2014 and headquartered in Singapore, specializes in drug discovery and cellular reprogramming. The company's core offering is a validated platform that combines artificial intelligence and genetic perturbation to uncover gene interactions and biological networks. This platform enables researchers and drug developers to create targeted therapies and apply precision medicine. Engine Biosciences caters to prominent American corporations and research institutions, accelerating and reducing the costs of R&D for new medical therapies.
Esco Lifesciences
Series A in 2021
Esco Lifesciences Group specializes in providing technology-based products and services tailored for the life sciences and healthcare sectors. The company supports a range of activities, including academic research, scientific discovery, clinical practice, and biopharmaceutical research and development. By offering innovative solutions, Esco Lifesciences aims to facilitate the invention, discovery, and commercialization of advancements in these fields, ultimately contributing to improved health and safety for individuals.
Hummingbird Bioscience
Series C in 2021
Hummingbird Bioscience is a biotechnology company specializing in the development of novel therapeutic antibodies for oncology and immuno-oncology indications. Utilizing systems biology approaches and proprietary computational platforms, they discover and engineer innovative biotherapeutics targeting challenging disease pathways with strong biological validation. Their pipeline includes lead assets HMBD-001 (anti-HER3) and HMBD-002 (anti-VISTA), both in cancer treatment. The company has formed strategic partnerships with Cancer Research UK and Amgen, and received a product development grant from the Cancer Prevention and Research Institute of Texas.
VNLIFE
Venture Round in 2021
VNLIFE is a technology company that develops a digital ecosystem for the tourism, logistics, and commerce sectors. It offers a range of digital products, including payment and service platforms, to individual consumers. The company aims to empower startups by providing technical expertise, business guidance, network building, and capital, enabling them to grow domestically and compete globally.
Neon Group
Private Equity Round in 2021
Neon Group is a global entertainment company headquartered in Singapore, specializing in creating and producing immersive experiences across various domains, including exhibitions, events, and interior architecture. The company has established partnerships with prominent organizations, including The Walt Disney Company, Marvel Entertainment, 20th Century Studios, and NBCUniversal, to develop popular themed exhibitions such as Marvel Avengers S.T.A.T.I.O.N. and Jurassic World: The Exhibition. Additionally, Neon collaborates with the governments of Peru and Egypt to present unique cultural experiences, showcasing original artifacts through exhibitions like Machu Picchu and Ramses the Great. With a commitment to delivering compelling and memorable experiences, Neon Group has successfully engaged millions of visitors across more than 60 cities worldwide, solidifying its position as a leader in the immersive entertainment industry.
ImmunoScape
Venture Round in 2021
ImmunoScape is a biotechnology company specializing in immunomics, focused on advancing immune profiling and characterization of the human immune response with high precision. The company utilizes its Deep Immunomics platform, which integrates mass cytometry, single-cell sequencing, and proprietary computational bioinformatics tools to deliver detailed and reproducible immune profiling data. This innovative approach supports various therapeutic areas, particularly oncology and infectious diseases, by enhancing the understanding of immunotherapy safety and efficacy while aiding in the identification of drug targets. Additionally, ImmunoScape offers a suite of software tools for immune cell profiling and antigen-specific T-cell identification, providing valuable insights during the research and development phases of immunotherapy clinical trials.
vArmour
Venture Round in 2021
vArmour Networks, Inc., established in 2011, specializes in software-defined security solutions for virtualized data centers. Headquartered in Mountain View, California, with offices in Calgary, Canada, and the UK, the company provides network-based security enforcement for cloud computing environments and a multi-cloud security architecture. vArmour's solutions separate the security control plane from the enforcement plane, offering vendor-agnostic security for hybrid cloud infrastructure. They cater to service providers, enterprises, and government cloud operators, with a strategic partnership with Tufin.
Pico is a prominent provider of technology services tailored for the financial markets sector. The company offers a comprehensive network platform that enables clients to access financial markets instantly. This platform is enhanced with advanced analytics and telemetry capabilities, ensuring transparency and low-latency solutions. Pico's innovative approach allows clients to operate efficiently and gain a competitive advantage in the rapidly evolving financial landscape. Its agile service delivery model further supports the needs of clients seeking to navigate the complexities of financial trading effectively.
Pear Therapeutics
Series D in 2020
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.
Gaiaworks
Series D in 2020
GaiaWorks is a developer of a cloud-based workforce management platform designed to enhance operational efficiency for organizations. The company’s solution integrates various functionalities, including time and attendance tracking, intelligent scheduling, and labor optimization, to simplify compliance and control labor costs. By utilizing data prediction based on the analysis of historical business metrics, such as sales volume and transaction numbers, GaiaWorks enables businesses to forecast labor needs effectively, typically on a weekly basis. This approach helps organizations improve labor efficiency, mitigate compliance risks, and enhance employee satisfaction.
Seismic Software
Series F in 2020
Seismic is a leading provider of sales enablement solutions that assist organizations in enhancing customer engagement and driving revenue growth. Its flagship product, the Seismic Enablement Cloud, is a comprehensive platform designed to equip customer-facing teams with essential skills, content, tools, and insights necessary for success. By automating the creation of personalized sales materials and leveraging data to identify effective content, Seismic improves sales performance by increasing close rates and facilitating larger deals. The company serves a diverse clientele, ranging from large enterprises to startups and small businesses, with over 2,000 organizations worldwide relying on Seismic to meet their enablement needs.
Biofourmis
Series C in 2020
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.
Livspace is an interior design startup that connects customers with designers, services, and products through its online platform. Founded in 2014 by Anuj Srivastava and Ramakant Sharma, the company specializes in providing end-to-end home interior services, enabling homeowners to discover and personalize a wide range of interior designs for various rooms. Livspace's proprietary design-to-installation platform, launched in 2016, aims to enhance the customer experience by streamlining the renovation process, from initial design concepts to final installation. This comprehensive approach allows customers to efficiently upgrade their homes with tailored solutions, making Livspace a key player in the home décor industry.
Aetion, Inc. is a healthcare analytics company that specializes in real-world evidence (RWE) and outcomes-based analytics solutions. Founded in 2012 and based in New York City, Aetion develops the Aetion Evidence Platform, which leverages everyday clinical and financial interactions within the healthcare system to generate critical insights about the effectiveness and value of medical treatments. This platform serves a diverse clientele, including life sciences companies, payers, providers, medical device manufacturers, and academic institutions, allowing them to analyze data from various sources such as claims, electronic health records, registries, and clinical trials. Aetion’s patented rapid-cycle analytics technology facilitates real-time collaboration among stakeholders, enabling them to make informed decisions and optimize patient care. The company has formed strategic partnerships with leading organizations, including McKesson, to enhance its offerings and expand its reach in the healthcare sector.
Rigetti Computing
Series C in 2020
Rigetti Computing is a full-stack quantum computing company that designs and manufactures quantum-integrated circuits, which are deployed in low-temperature environments. The company develops control systems that perform quantum logic operations and has created software to seamlessly integrate its quantum systems into existing cloud infrastructures. Rigetti is known for its development of the industry's first multi-chip quantum processor, enabling scalable quantum computing systems. Additionally, the company focuses on practical applications of quantum computing, particularly in computational chemistry and machine learning, and has introduced Forest, a comprehensive programming and execution environment for quantum and classical computing. The majority of its revenue is generated from the United States.
Vesta
Venture Round in 2020
Vesta Corporation is a provider of electronic payment solutions, specializing in client-branded services that enhance payment processing for merchants. The company offers a range of merchant solutions, including vSafe for Small to Midsize Businesses, which focuses on payment and fraud protection for smaller digital goods merchants, and vSafe for Enterprise, designed for comprehensive payments management and enterprise-level fraud prevention. Additionally, Vesta provides vGuaranteed, a payment solution tailored for online retailers, and DelayPay, a retail installment program that allows prepaid wireless customers to pay for services in installments. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally, with centers in the United States, Ireland, China, and an office in Singapore. The company serves diverse industries, including e-commerce, telecommunications, and financial services, processing hundreds of millions of secure payments across various channels while prioritizing data security and fraud loss elimination.
Transcelestial
Series A in 2020
Transcelestial Technologies Pte. Ltd. is a Singapore-based company established in 2016 that specializes in developing advanced wireless communication infrastructure. The company focuses on creating a long-distance, point-to-point wireless communication network utilizing laser technology to transfer data at speeds up to 1000 times faster than current capabilities. This innovative approach aims to provide a robust space data network for both terrestrial and satellite applications, ensuring high-speed connectivity that is difficult to disrupt and does not require spectrum pre-allocation or regulation. Transcelestial's solutions are designed to enhance data transfer for a variety of clients, enabling reliable and rapid network services on a global scale.
Erasca, Inc. is a clinical-stage precision oncology company based in San Diego, California, focused on discovering and developing therapies for patients with cancers driven by the RAS/MAPK pathway. Founded in 2018, the company employs an artificial intelligence drug discovery platform known as OPRA, which utilizes machine learning to analyze large-scale data sets and identify novel tumor biology, thereby accelerating drug development. Erasca is developing a pipeline of oncology drugs, including Naporafenib, an innovative pan-RAF inhibitor aimed at treating NRAS-mutant melanoma and other RAS/MAPK-driven tumors. Additionally, the company is advancing ERAS-007, an oral ERK1/2 inhibitor, and ERAS-601, an oral SHP2 inhibitor, targeting key nodes in the RAS/MAPK signaling pathway. Through its research and collaborations, Erasca aims to provide precision oncology options that offer potential solutions for treating and possibly curing cancer.
Screening Eagle
Series A in 2020
Screening Eagle Technologies AG is a Swiss company that specializes in developing a cloud-based technology platform for the intelligent inspection of assets and infrastructure. Founded in 2019, the company emerged from the merger of Dreamlab, a software and robotics firm, and Proceq, a long-established leader in portable non-destructive testing sensors. Screening Eagle's platform integrates sensors, software, and data to enhance asset inspection processes, offering tools for project management, workflow automation, and data analysis. Its solutions cover a wide range of industrial surface testing applications, including concrete and road assessments, flaw detection, and hardness testing across various materials. By leveraging artificial intelligence, Screening Eagle provides real-time analytical tools that enable organizations to conduct data-driven inspections and manage asset health effectively.
Doctor Anywhere
Series B in 2020
Doctor Anywhere is a Singapore-based telehealth company that offers a comprehensive digital platform for on-demand healthcare solutions. It provides quick access to a range of health and wellness services, allowing users to consult licensed medical professionals for diagnoses, medications, and e-prescriptions from anywhere and at any time. The platform is designed to be simple and convenient, catering to the evolving lifestyle preferences of modern users. By leveraging technology, Doctor Anywhere aims to enhance health outcomes and address contemporary healthcare challenges, making it easier for individuals to manage their health according to their specific needs.
ElevateBio
Series B in 2020
ElevateBio, LLC is a holding company based in Cambridge, Massachusetts, founded in 2017. It focuses on developing cell and gene therapies for the treatment of cancer and viral infections. The company operates a portfolio of subsidiaries that aim to manufacture and commercialize innovative medicines. ElevateBio collaborates with leading scientists and inventors to create a robust portfolio of therapeutic solutions. Additionally, it has established a centralized facility designed to streamline the translation of cell and gene therapy research into viable medical products, ensuring that patients have access to treatments for severe diseases in a timely manner.
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.
Eko Health
Venture Round in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.
eko.ai
Funding Round in 2020
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.
SWAT Mobility
Series A in 2019
SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.
M-DAQ
Venture Round in 2019
M-DAQ Pte Ltd is an innovative company that specializes in providing a platform for cross-border transactions, enabling users to price and trade exchange-traded products in multiple currencies. Founded by industry veterans with extensive experience in foreign exchange and securities, M-DAQ blends executable foreign exchange rates into equities and futures products. This unique solution allows traders and security exchanges to operate in a multi-currency environment without requiring significant changes to their existing systems and back-end processes. M-DAQ maintains key relationships with national exchanges and global foreign exchange banks and handles the consultancy work necessary for exchanges to utilize its solution. Additionally, partner exchanges can earn revenue through a share of the net foreign exchange margins generated by the platform, all while operating within their respective regulatory frameworks.
Neon Group
Private Equity Round in 2019
Neon Group is a global entertainment company headquartered in Singapore, specializing in creating and producing immersive experiences across various domains, including exhibitions, events, and interior architecture. The company has established partnerships with prominent organizations, including The Walt Disney Company, Marvel Entertainment, 20th Century Studios, and NBCUniversal, to develop popular themed exhibitions such as Marvel Avengers S.T.A.T.I.O.N. and Jurassic World: The Exhibition. Additionally, Neon collaborates with the governments of Peru and Egypt to present unique cultural experiences, showcasing original artifacts through exhibitions like Machu Picchu and Ramses the Great. With a commitment to delivering compelling and memorable experiences, Neon Group has successfully engaged millions of visitors across more than 60 cities worldwide, solidifying its position as a leader in the immersive entertainment industry.
Nuvation Bio
Series A in 2019
Nuvation Bio Inc. is a biopharmaceutical company dedicated to addressing unmet needs in oncology through the development of novel therapies for challenging cancers. Founded in 2018 and headquartered in New York, with an additional office in San Francisco, Nuvation Bio focuses on treating patients whose conditions have not responded to conventional treatments. The company's leading clinical-stage candidate, NUV-868, is a BD2-selective oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. In addition to NUV-868, Nuvation Bio is advancing a proprietary small molecule Drug-Drug Conjugate platform aimed at enhancing therapeutic efficacy. The company’s comprehensive portfolio includes multiple drug development candidates designed to meet the specific needs of cancer patients.
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its proprietary hardware technology. By focusing on enhancing the speed and efficiency of 3D printing, Structo enables users to achieve higher throughput at lower costs compared to traditional stereolithography (SLA) printers. Their innovative approach allows dental professionals to revolutionize their business models while maintaining high print quality.
DataRobot
Series E in 2019
DataRobot, Inc. is a Boston-based company that specializes in developing an automated machine learning platform aimed at empowering enterprises to construct predictive models efficiently. Its offerings include DataRobot Cloud, a cloud-based platform for predictive analytics, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. Additionally, DataRobot Enterprise provides features tailored for large organizations, such as flexible deployment options, governance, and comprehensive support. The company's solutions cater to a diverse clientele, including business analysts, data scientists, executives, and IT professionals across various sectors such as banking, healthcare, and manufacturing. Founded in 2012, DataRobot has expanded its operations internationally, with locations in London, Paris, Kyiv, Tokyo, and Singapore, and maintains a strategic partnership with Snowflake to enhance its offerings.
Inari is a biotechnology company focused on revolutionizing agriculture and its societal and environmental impact. The company utilizes advanced technologies, including predictive design and multiplex gene editing, to maximize the potential of seeds. Its unique SEEDesign platform distinguishes Inari by enabling the enhancement of various crops across different geographies, facilitating the development of innovative agricultural products. By embracing diversity, Inari fosters innovation and aims to contribute to the creation of a new food system.
Circles.Life
Venture Round in 2019
Circles.Life is a digital telecommunications company based in Singapore that aims to transform mobile services by focusing on customer needs. The company offers post-paid mobile and internet data services through subscription-based plans, which can be conveniently managed via a customized mobile application. This platform allows users to track their data usage, monitor costs, and seamlessly browse and switch between various data plans. With a commitment to providing no-contract mobile plans and unlimited bonus data, Circles.Life prioritizes delivering an exceptional customer experience.
Biofourmis
Series B in 2019
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.
Zilingo is a technology-driven platform founded in 2015 by Ankiti Bose and Dhruv Kapoor, aimed at transforming the fashion supply chain through innovative trade solutions. By digitizing the fashion industry, Zilingo provides a marketplace that connects brands and merchants directly with factories, offering essential tools such as analytics, efficient logistics, and secure payment options. This approach enables entrepreneurs to thrive in a sector that has historically favored a select few, promoting accessibility, transparency, and connection within the fashion ecosystem. Zilingo's vision is to democratize fashion, making it possible for anyone with the right ideas to succeed in the industry.
Pear Therapeutics
Series C in 2019
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.
Pindrop is a developer of advanced phone fraud detection and call center authentication technology, focused on enhancing security, identity, and trust in voice interactions. The company offers solutions that authenticate phone devices through call audio analysis, enabling the detection of fraudulent calls and the verification of legitimate callers. By leveraging a comprehensive risk database, Pindrop's technology helps enterprise call centers and businesses streamline communication, reduce call handling time, and improve customer experience while minimizing fraud losses. With a commitment to unlocking the value of voice interactions, Pindrop is positioned to support both enterprises and consumers in navigating a voice-driven future.
WalkMe Inc., founded in 2011 and headquartered in San Francisco, California, develops a cloud-based guidance and engagement platform designed to enhance user experience and productivity. Their Digital Adoption Platform adapts software to meet the needs of employees and customers, while WalkMe Automation simplifies user experiences by automating complex tasks. The company also offers solutions for modernizing legacy desktop applications and enhancing security. WalkMe's platform integrates with various systems, including Salesforce and Workday, and serves sectors such as financial services, healthcare, insurance, retail, software, utility, and education. With additional offices in New York, Raleigh, London, Tel Aviv-Yafo, Sydney, and Tokyo, WalkMe is a subsidiary of WalkMe Ltd.
Ambiq Micro
Series E in 2018
Ambiq Micro, Inc. is a fabless semiconductor company based in Austin, Texas, specializing in the development of ultra-low power integrated circuits tailored for power-sensitive applications. Founded in 2010, the company utilizes innovative subthreshold power optimized technology to create real-time clock and microcontroller products designed for wearables, smart cards, wireless sensors, and Internet-of-Things devices. By focusing on ultra-low-power mixed-signal solutions, Ambiq Micro aims to enhance the efficiency of wireless electronics, facilitating the creation of devices that either minimize or eliminate battery use while maximizing design flexibility. The company also provides technical support services and operates additional offices in San Jose, California, as well as in Shanghai, Shenzhen, and Taiwan.
Moka is a Jakarta-based technology company that specializes in developing a cloud-based point-of-sale application and integrated card reader solutions for small and medium-sized businesses. Founded in 2014, Moka's application enables users to process payments via debit and credit cards while also providing features such as sales reporting across multiple outlets, inventory tracking, customer feedback collection, and analytics. The company offers a range of hardware, including Apple iPads, printers, cash drawers, barcode scanners, and mobile point-of-sale devices, catering to various sectors such as coffee shops, barbershops, retail stores, and restaurants, as well as mobile vendors like food trucks and kiosks. Moka operates on a subscription-based model, charging users a monthly fee that varies according to the number of locations they manage. This approach allows business owners to access real-time sales data stored in the cloud from any location.
OakNorth Bank
Series B in 2018
OakNorth Bank, established in 2015, is a digital-only commercial bank based in London, UK. It specializes in serving small-to-medium sized businesses (SMEs) that are often overlooked by traditional banks. The bank offers a range of financial products, including business and personal savings accounts, fixed term deposits, and property finance solutions. OakNorth's core strength lies in its bespoke debt finance solutions, catering to the growth plans of businesses without requiring equity. It has lent over £10 billion to date, supporting various sectors such as property developers, care homes, and hospitality businesses. The bank's data-led approach enables it to make forward-looking decisions, acting as a reliable, long-term partner to its customers.
I-Mab Biopharma
Series C in 2018
I-Mab Biopharma (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the fields of immuno-oncology and immuno-inflammation. I-Mab's diverse drug pipeline targets various therapeutic areas, including multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, and several cancer indications such as head and neck cancer. Key candidates in its portfolio include Uliledlimab, an antibody for solid tumors, along with Ragistomig and Givastomig, highlighting the company's commitment to developing transformative therapies for patients.
Puppet is an information technology company that specializes in automation solutions aimed at addressing common business challenges. The company offers a comprehensive platform for infrastructure automation, covering areas such as configuration management, compliance, application delivery, and patch management. Puppet's tools facilitate the development, management, version control, and code analysis necessary for effective IT operations. By enabling clients to deliver, update, monitor, and secure software across both physical and virtual machines, Puppet enhances operational efficiency and reliability in IT environments.
Bitmain is a leading manufacturer of Bitcoin mining hardware, specializing in the development and sale of miners utilizing ASIC chip technology. Founded by pioneers in the digital currency sector, the company is staffed by a team of skilled engineers, financial experts, and cryptocurrency enthusiasts. Headquartered in Beijing, Bitmain also maintains offices in cities such as San Francisco, Tel Aviv, Hong Kong, Chengdu, and Shenzhen. The company focuses on providing high-quality, efficient computing solutions, including high-density server equipment and large-scale parallel computing software, to support the cryptocurrency mining industry.
Carousell
Series C in 2018
Carousell is a Singapore-based classifieds marketplace that facilitates the buying and selling of preloved items through its mobile app, available on iOS and Android. Launched in August 2012, the platform allows users to easily list their secondhand goods by simply taking a photo and adding a description, covering a wide array of categories such as fashion, electronics, home goods, and vehicles. Carousell has gained popularity and recognition, ranking as the top shopping app in several regions including Singapore, Taiwan, Hong Kong, and Australia. The company has expanded its reach to 19 cities across seven countries, driven by a mission to inspire individuals to start selling and declutter their lives while enabling others to discover savings.
Rotimatic
Series C in 2018
Zimplistic, founded in 2008 by Rishi Israni and Pranoti Nagarkar, is a kitchen robotics startup focused on improving healthy eating through innovative technology. Its flagship product, Rotimatic, is the world's first fully automatic roti-making appliance that uses artificial intelligence to create fresh, homemade flatbreads with minimal human intervention. Launched in 2016, Rotimatic processes essential ingredients and produces hot, delicious rotis in under a minute, offering a user-friendly solution for busy households. The appliance has gained significant popularity, serving over 3 million rotis in thousands of homes by mid-2017. Available in several countries including Singapore, the US, the UK, Canada, Australia, and New Zealand, Rotimatic aims to simplify meal preparation and promote healthier eating habits by enabling users to enjoy homemade food made from carefully selected ingredients.
H3 Dynamics
Series B in 2018
H3 Dynamics is a company specializing in high-performance hydrogen solutions tailored for the aerospace and defense sectors. With offices in Toulouse, Austin, and Singapore, H3 Dynamics boasts over 16 years of research and development experience, positioning itself as a pioneer in hydrogen flight technology. The company focuses on advancing hydrogen-electric fuel cell systems for various applications, including extending the operational range of small electric unmanned aerial systems and powering large-scale passenger aircraft. Additionally, H3 Dynamics offers on-site hydrogen production and refueling services for airports and drone operators, particularly in remote locations. The company also develops telerobotics drones that transform complex data from images, videos, and sensor inputs into expert-validated inspection reports, providing essential aerial analytics and delivery services to asset owners and operators.